FE9-24744-07295
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 641 / MO
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Pfizer-BioNTech
-
2021-03-16
Registered in v-safe
-
2021-03-16
Survey response — day 7, dose 1MedDRA: Breast swelling, Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, Rash, Rash erythematous — Feeling: Fair · Site: Redness, ItchingFree text: Two days after I received the vaccine I noticed redness swelling and itching and my upper left arm where I receive the vaccination. The area increased to about 2 x 4 and later spread by the next morning to redness in my left axilla and upper left breast area with swelling as well. There I was also painful. The itching is still present and some redness in my upper arm. The issue in my breast has resolved at this time.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
-
2021-04-08
Dose 2 — Pfizer-BioNTech
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech |
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): Two days after I received the vaccine I noticed redness swelling and itching and my upper left arm where I receive the vaccination. The area increased to about 2 x 4 and later spread by the next morning to redness in my left axilla and upper left breast area with swelling as well. There I was also painful. The itching is still present and some redness in my upper arm. The issue in my breast has resolved at this time.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Breast swelling | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash erythematous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release